As of August 28, 2026, Chemomab Therapeutics Ltd. (CMMB) has a DilutionWatch DilutionScore of 62/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Chemomab Therapeutics Ltd. has a market capitalization of $14.40M, 575.38M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 35%
🔄 Reverse Split
model est. 45%
• 50-day avg $1.69 approaching $1 threshold
• Only 6 months cash — financial pressure
💰 Capital Raise
model 35%
• Low cash runway: 6 months remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (62/100)
Market Data
Market Cap$14.40M
Shares Outstanding575.38M
FloatN/A
Cash$7.56M
DebtN/A
Short InterestN/A
Institutional Holdings
7.9% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest155.6K
Days to Cover2.2
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track CMMB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMMB — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.